Drugs / QAX028
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01068613 | Jan → Aug 2010 | chronic obstructive pulmonary disease | Novartis Pharmaceuticals | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00568503 Comparator | Oct 2007 → Feb 2008 | chronic obstructive pulmonary disease | Novartis | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | QAX028 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01068613 ↗ |
| Route | Inhaled | “QAX028 60 mcg via inhalation device” NCT01068613 ↗ |